Qing Ling

Qingchun Road 79#
Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Characteristics and Prognostic Implications in Newly Diagnosed KMT2Ar AML: A Multicenter Study of the ECLA Group.

Characteristics and Prognostic Implications in Newly Diagnosed KMT2Ar AML: A Multicenter Study of the ECLA Group.

Journal: American journal of hematology

Published: December 12, 2025

IDH1-mutated B-cell acute lymphoblastic leukemia characterized by oncogenic reprogramming of lipid metabolism.

IDH1-mutated B-cell acute lymphoblastic leukemia characterized by oncogenic reprogramming of lipid metabolism.

Journal: Haematologica

Published: June 17, 2025

NSUN2-mediated cytosine-5 methylation of FSP1 protects acute myeloid leukemia cells from ferroptosis.

NSUN2-mediated cytosine-5 methylation of FSP1 protects acute myeloid leukemia cells from ferroptosis.

Journal: Molecular cancer

Published: March 27, 2025

Sirt1 m6A modification-evoked Leydig cell senescence promotes Cd-induced testosterone decline.

Sirt1 m6A modification-evoked Leydig cell senescence promotes Cd-induced testosterone decline.

Journal: Ecotoxicology and environmental safety

Published: May 09, 2024

Osteolytic lesion as initial presentation in FIP1L1-PDGFRA-rearranged myeloid/lymphoid neoplasm with eosinophilia: a case report.

Osteolytic lesion as initial presentation in FIP1L1-PDGFRA-rearranged myeloid/lymphoid neoplasm with eosinophilia: a case report.

Journal: Annals of hematology

Published: August 13, 2023

Repressing HIF-1α-induced HDAC9 contributes to the synergistic effect of venetoclax and MENIN inhibitor in KMT2Ar AML.

Repressing HIF-1α-induced HDAC9 contributes to the synergistic effect of venetoclax and MENIN inhibitor in KMT2Ar AML.

Journal: Biomarker research

Published: August 06, 2023

CPT1B, a metabolic molecule, is also an independent risk factor in CN-AML.

CPT1B, a metabolic molecule, is also an independent risk factor in CN-AML.

Journal: Cancer biomarkers : section A of Disease markers

Published: March 20, 2023

circSLC25A13 acts as a ceRNA to regulate AML progression via miR-616-3p/ADCY2 axis.

circSLC25A13 acts as a ceRNA to regulate AML progression via miR-616-3p/ADCY2 axis.

Journal: Molecular carcinogenesis

Published: January 31, 2023

High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response.

High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: January 21, 2023

Spermatogenesis associated serine rich 2 like plays a prognostic factor and therapeutic target in acute myeloid leukemia by regulating the JAK2/STAT3/STAT5 axis.

Spermatogenesis associated serine rich 2 like plays a prognostic factor and therapeutic target in acute myeloid leukemia by regulating the JAK2/STAT3/STAT5 axis.

Journal: Journal of translational medicine

Published: November 11, 2022

Magnetic soft robotic bladder for assisted urination.

Magnetic soft robotic bladder for assisted urination.

Journal: Science advances

Published: August 24, 2022

ACC010, a novel BRD4 inhibitor, synergized with homoharringtonine in acute myeloid leukemia with FLT3-ITD.

ACC010, a novel BRD4 inhibitor, synergized with homoharringtonine in acute myeloid leukemia with FLT3-ITD.

Journal: Molecular oncology

Published: July 21, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026